These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18337424)

  • 1. Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro.
    Doly S; Valjent E; Setola V; Callebert J; Hervé D; Launay JM; Maroteaux L
    J Neurosci; 2008 Mar; 28(11):2933-40. PubMed ID: 18337424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice.
    Doly S; Bertran-Gonzalez J; Callebert J; Bruneau A; Banas SM; Belmer A; Boutourlinsky K; Hervé D; Launay JM; Maroteaux L
    PLoS One; 2009 Nov; 4(11):e7952. PubMed ID: 19956756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
    Bankson MG; Yamamoto BK
    J Neurochem; 2004 Nov; 91(4):852-9. PubMed ID: 15525339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
    Mlinar B; Corradetti R
    Eur J Neurosci; 2003 Sep; 18(6):1559-71. PubMed ID: 14511335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
    Bankson MG; Cunningham KA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):846-52. PubMed ID: 11356903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
    Urban NB; Girgis RR; Talbot PS; Kegeles LS; Xu X; Frankle WG; Hart CL; Slifstein M; Abi-Dargham A; Laruelle M
    Neuropsychopharmacology; 2012 May; 37(6):1465-73. PubMed ID: 22353758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1998 Oct; 19(4):265-77. PubMed ID: 9718590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
    Morley KC; Arnold JC; McGregor IS
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.
    Gudelsky GA; Yamamoto BK
    Pharmacol Biochem Behav; 2008 Aug; 90(2):198-207. PubMed ID: 18035407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
    Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
    Fantegrossi WE; Kiessel CL; De la Garza R; Woods JH
    Psychopharmacology (Berl); 2005 Sep; 181(3):529-36. PubMed ID: 15983787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
    Setola V; Hufeisen SJ; Grande-Allen KJ; Vesely I; Glennon RA; Blough B; Rothman RB; Roth BL
    Mol Pharmacol; 2003 Jun; 63(6):1223-9. PubMed ID: 12761331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
    Ball KT; Rebec GV
    Psychopharmacology (Berl); 2005 Oct; 181(4):676-87. PubMed ID: 16001122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor.
    Amato JL; Bankson MG; Yamamoto BK
    Neuropsychopharmacology; 2007 Apr; 32(4):946-54. PubMed ID: 16885935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adenosine A1 and A2A receptors in the caffeine effect on MDMA-induced DA and 5-HT release in the mouse striatum.
    Górska AM; Gołembiowska K
    Neurotox Res; 2015 Apr; 27(3):229-45. PubMed ID: 25391902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDMA induces EPSP-Spike potentiation in rat ventral hippocampus in vitro via serotonin and noradrenaline release and coactivation of 5-HT4 and beta1 receptors.
    Mlinar B; Mascalchi S; Morini R; Giachi F; Corradetti R
    Neuropsychopharmacology; 2008 May; 33(6):1464-75. PubMed ID: 17653110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
    Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
    J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
    Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
    Neuropsychopharmacology; 2005 Mar; 30(3):550-60. PubMed ID: 15496938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
    Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.